Today: 23 January 2026
Subscribe
Browse Category

NASDAQ:VKTX News 13 January 2026 - 14 January 2026

Structure Therapeutics stock jumps as Novo deal talk lifts obesity-drug names

Structure Therapeutics stock jumps as Novo deal talk lifts obesity-drug names

New York, January 14, 2026, 13:46 EST — Regular session Shares of Structure Therapeutics (GPCR) jumped roughly 7.5% Wednesday, as traders returned to small-cap obesity drugmakers. The stock climbed to $83.76, trading over 1 million shares. This shift is crucial as investors wager the weight-loss craze will move from weekly injections to pills, reshaping the buyout landscape. A Novo Nordisk…
14 January 2026
········
Viking Therapeutics stock jumps 11% as CEO flags broader appetite for obesity-drug deals

Viking Therapeutics stock jumps 11% as CEO flags broader appetite for obesity-drug deals

New York, January 14, 2026, 13:09 EST — Regular session underway. Shares of Viking Therapeutics climbed roughly 11% on Wednesday, rising from a $30.44–$34.08 range to $34.06 by 1:09 p.m. EST. The move came amid renewed deal speculation in obesity treatments. CEO Brian Lian noted that interest was “broader than is visible” with more players “circling around the space.” Analysts…
14 January 2026
····
Pfizer stock slips as CEO says obesity cash-pay market is “almost like Viagra”

Pfizer stock slips as CEO says obesity cash-pay market is “almost like Viagra”

New York, Jan 13, 2026, 10:50 (EST) — Regular session Pfizer Inc (PFE) shares slipped about 0.7% to $25.10 Tuesday morning as investors digested the company’s latest obesity drug strategy unveiled at the J.P. Morgan Healthcare Conference in San Francisco. CEO Albert Bourla described the booming out-of-pocket weight-loss market as “almost like Viagra” now. Pfizer aims to launch 10 phase…
13 January 2026
·····

Stock Market Today

  • Anteris Technologies Global's Market Cap Soars AU$609m; Individual Investors Lead Gains
    January 23, 2026, 4:29 PM EST. Anteris Technologies Global Corp (ASX:AVR) saw its market capitalization rise by AU$609 million last week, with individual investors holding approximately 25% of shares benefiting the most. Institutions owned 17%, reflecting some professional confidence, led by L1 Capital Pty. Limited at 20%, BlackRock at 4.9%, and Sio Capital Management at 4.3%. Despite institutional involvement, the company's ownership is dispersed, with no single majority shareholder. This breadth of shareholder distribution indicates individual investors collectively hold significant influence over company strategy. Analysts remain active on ASX:AVR, suggesting continued market interest and the potential for stock volatility depending on institutional sentiment and earnings performance.
Go toTop